We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr, Mylan File to Make Generic Versions of Fosrenol
Barr, Mylan File to Make Generic Versions of Fosrenol
February 9, 2009
British drugmaker Shire is reviewing its options after receiving separate notices that Barr Laboratories and Mylan intend to manufacture generic versions of the kidney disease treatment Fosrenol before patent protection expires.